Avient CorpAVNT

The first thing Avient’s latest 10-Q shows is $847.4 million in revenue for the quarter ending 31 March 2026, up 3% year-over-year and boosted by a 5% foreign-exchange tailwind. Net income came in at $55.7 million, operating income at $95.8 million, and diluted EPS at $0.61 on 91.9 million shares. The catch? Operating cash flow was minus $34.5 million, while inventories swelled by $22.9 million. If Avient’s polished story is about sustainable polymers and advanced composites, the balance-sheet reality is about growing sales while haemorrhaging operating cash.

Avient describes itself as a global manufacturer of advanced composites, specialty polymers, colour and additive systems, and thermoplastic and polymer compounds that enhance performance and protect the environment. The company’s website showcases product pages and sustainability messaging, but the filings tell a different tale: inventories up, operating cash flow down, and R&D expense of $96.7 million in the year to December 2025 against net profit of $55.7 million. The gap between platform and ledger is wide enough to park a polymer extruder.

The latest 10-Q details revenue of $847.4 million, net income of $55.7 million, operating income of $95.8 million, diluted EPS of $0.61 on 91.9 million shares, operating cash flow of minus $34.5 million, and inventories of $386.4 million with an increase of $22.9 million in the quarter. Assets stood at $5.94 billion and equity at $2.41 billion. R&D expense for the year to December 2025 was $96.7 million. The company’s weighted-average diluted shares outstanding were 91.9 million, and payments for property, plant and equipment were $19.0 million.

For a company whose website markets advanced materials and sustainability, the filing evidence is heavier on inventory build and lighter on cash generation. The operating cash flow deficit and rising inventories are the operative facts; the rest is brochure copy. The source rail does not supply segment-level cash flow or guidance, so the source requires readers to read the filings for operating realities rather than polished narratives. TradingView route for AVNT is available via the issuer’s investor relations pages.

What changed this quarter is the inventory build and the operating cash outflow, neither of which appears in the platform story. What remains unproven is whether the company can convert rising sales into durable operating cash flow or whether the R&D spend is seeding future margins or simply burning equity incentives. Evidence that would deepen the file includes a segment-level cash-flow breakdown, explicit guidance, and a clear articulation of how the inventory build is temporary and value-accretive rather than structural.

The board’s 2026 award agreement confirms that absence won’t interrupt service under the plan, which is corporate-speak for ‘equity incentives stay vested even on leave.’ The filing rail does not supply insider-trading patterns or 8-K events beyond routine officer changes, so governance risk is inferred rather than evidenced. The company’s press release on first-quarter 2026 results confirms the 3% sales growth and 5% FX tailwind, but omits segment detail or cash-flow commentary.